Standards for the provision of antenatal care for patients with inflammatory bowel disease: guidance endorsed by the British Society of Gastroenterology and the British Maternal and Fetal Medicine Society
Autor: | Veronica Hall, Aileen Fraser, Marie Smith, Lyn A. Smith, Klaartje Kok, Nicola Carey, Christian P. Selinger, Shelley Cassere, Aarthi Mohan, Melanie Gunn, Catherine Nelson-Piercy, Kate Harding, Tracey Glanville, Khasia Mulgabal, Alexandra Kent, Jimmy K. Limdi |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2021 |
Předmět: |
medicine.medical_specialty
Pregnancy Crohn's disease Hepatology business.industry Gastroenterology Audit medicine.disease Inflammatory bowel disease digestive system diseases 03 medical and health sciences 0302 clinical medicine Documentation 030220 oncology & carcinogenesis Family medicine Health care medicine 030211 gastroenterology & hepatology business Breast feeding Inclusion (education) Colorectal |
Zdroj: | Frontline Gastroenterol |
ISSN: | 2041-4137 |
Popis: | BackgroundPregnant women with inflammatory bowel disease (IBD) are at increased risk of adverse pregnancy outcomes. Comprehensive guidelines on medical management have been published; yet, there is limited guidance on service set-up and minimum standards of care for pregnant women with IBD.AimTo develop a position statement on service set-up and minimum standards of care in the UK.MethodsA working group consisting of 16 gastroenterologists, obstetricians, obstetric physician, IBD specialist nurses and midwives was assembled. Initial draft statements were produced and a modified Delphi process with two rounds of voting applied. Statements were modified according to voters’ feedback after each round. Statements with ≥80% agreement were accepted.ResultsAll 15 statements met criteria for inclusion. To facilitate optimal care, regular and effective communication between IBD and obstetric teams is required. There should be nominated link clinicians for IBD in obstetric units and for pregnancy in IBD units. Preconception counselling should be available for all women with IBD. All pregnant women should be advised on the safety of IBD medication during pregnancy and breast feeding, the optimal mode of delivery, the management of biologics (where applicable) and safety of childhood vaccinations. Regular audit of pregnancy outcomes and documentation of advice given is recommended.ConclusionPosition statements have been developed that advise on the importance of joined-up multidisciplinary care, proactive decision-making with clear documentation and communication to the woman and other healthcare practitioners. |
Databáze: | OpenAIRE |
Externí odkaz: |